Concepedia

Krzysztof Lesniewski- Kmak

KL

Statistics

Publications

2

Citations

3.4K

H-Index

2

Active since

2005

Affiliations

Guangdong Academy of Medical Sciences(Current)

Krzysztof Lesniewski- Kmak is an author at Guangdong Academy of Medical Sciences specializing in medicine, oncology, and metastasis.

Publications per year

2005–2019

2

Publications

2

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

, , +15

Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer

Arkadiusz Z. Dudek, Krzysztof Lesniewski- Kmak, Joseph S. Koopmeiners et al. · Lung Cancer · 2005 · 59 citations

, , +16

1–2 of 2